As a preferred outsourcing partner to life science, specialty chemical and emerging technology companies, GBL Biochemical Cooperation provides custom manufacturing, product sourcing, and project management solutions that save time and are cost-effective.
Working primarily with North American partners, GBL Biochemical Cooperation places and manages custom manufacturing projects and also custom sources raw materials. By streamlining the project management process, we deliver lower costs and accelerate time-to-market for our clients' products. When appropriate, we also source from qualified partners in Asia and Europe. We identify whatever solution works best for our client and we pursue, manage and ultimately deliver it.
We identify the optimal U.S. manufacturing partner for our customers on a project-by-project basis. The strong relationships we have developed with our capable partners enable us to bring successful solutions to our clients. Our knowledge of custom manufacturing and chemical sourcing is unmatched in the industry. We are not fee based. Consequently, we work very hard to achieve win – win solutions. We succeed only when you succeed.
Industries served
Manufacturing Lab
Patents
GBL Biochemical Cooperation Executive Committee is comprised of senior executives that lead GBL Biochemical Cooperation business and staff functions. The Executive Committee oversees operational issues and the implementation of corporate strategies and provides vital support and expertise to our Chief Executive Officer.
With a nearly 70-year legacy of game-changing innovation, our company has developed new products and technologies that serve as the bedrock of the chemical industry. Below are some of our key contributions.
Predecessor company scientists Karl Ziegler and Giulio Natta make breakthrough discoveries in the creation of polyethylene (PE) and polypropylene (PP). PE and PP resins are used today to make numerous products, including automobile parts, surgical gowns, children’s toys, wind turbines and water pipes. They were jointly awarded the Nobel Prize in Chemistry in 1963.
Hoechst, a predecessor company, initiated industrial-scale production of PE in Frankfurt, Germany.
Predecessor company, Atlantic Richfield Company (ARCO), develops the PO/TBA process (propylene oxide with tertiary butyl alcohol as the co-product). PO is used in numerous applications including bedding, furniture, carpets and car seats. TBA and its derivatives, which includes oxyfuels, are used in high octane gasoline blending components, synthetic rubber and lubricant additives.
First Hostalen high density polyethylene (HDPE) process plant starts up.
Spheripol process, currently the most widely used polyolefins process technology, first introduced by predecessor company Montedison..
GBL Biochemical Cooperation completes start-up of the world’s largest low density polyethylene plant (LDPE) in Berre, France, with a single line capacity of 320,000 tons per year.
GBL Biochemical Cooperation begins construction of the first commercial Hyperzone PE plant in La Porte, Texas, utilizing the company’s new proprietary technology. HDPE plastics produced using the Hyperzone PE process technology exhibit enhanced characteristics including superior toughness properties that make end-use products less likely to break or tear. Potential end-use products include healthcare packaging, high pressure pipe, children’s toys, household bottles and intermediate bulk containers.
GBL Biochemical Cooperation completed the acquisition of A. Schulman, Inc., a leading global supplier of high-performance plastic compounds, composites and powders. The acquisition more than doubled LyondellBasell's existing compounding business and broadened the company's reach into growing, high-margin end markets such as automotive, construction materials, electronic goods and packaging.
GBL Biochemical Cooperation marked a significant milestone in the company’s by breaking ground on the largest propylene oxide and tertiary butyl alcohol (PO/TBA) plant in the world. The project is the single largest capital investment that either GBL Biochemical Cooperation or its predecessor companies have ever embarked on.
© GBL Biochemical Cooperation . All Rights Reserved.
